BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23077096)

  • 1. Liver X receptor agonists decrease ENaC-mediated sodium transport in collecting duct cells.
    Soodvilai S; Jia Z; Fongsupa S; Chatsudthipong V; Yang T
    Am J Physiol Renal Physiol; 2012 Dec; 303(12):F1610-6. PubMed ID: 23077096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver X receptor activation inhibits SGLT2-mediated glucose transport in human renal proximal tubular cells.
    Chonlaket P; Wongwan T; Soodvilai S
    Exp Physiol; 2018 Feb; 103(2):250-260. PubMed ID: 29127736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of liver X receptor inhibits OCT2-mediated organic cation transport in renal proximal tubular cells.
    Wongwan T; Kittayaruksakul S; Asavapanumas N; Chatsudthipong V; Soodvilai S
    Pflugers Arch; 2017 Nov; 469(11):1471-1481. PubMed ID: 28741179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of liver X receptors reduces CFTR-mediated Cl(-) transport in kidney collecting duct cells.
    Raksaseri P; Chatsudthipong V; Muanprasat C; Soodvilai S
    Am J Physiol Renal Physiol; 2013 Aug; 305(4):F583-91. PubMed ID: 23720350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver X receptor activation downregulates organic anion transporter 1 (OAT1) in the renal proximal tubule.
    Kittayaruksakul S; Soodvilai S; Asavapanumas N; Muanprasat C; Chatsudthipong V
    Am J Physiol Renal Physiol; 2012 Mar; 302(5):F552-60. PubMed ID: 22169006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of epithelial Na+ transport by soluble adenylyl cyclase in kidney collecting duct cells.
    Hallows KR; Wang H; Edinger RS; Butterworth MB; Oyster NM; Li H; Buck J; Levin LR; Johnson JP; Pastor-Soler NM
    J Biol Chem; 2009 Feb; 284(9):5774-83. PubMed ID: 19126549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent effect of liver X receptor agonists on prostate-specific antigen expression is dependent on androgen receptor in prostate carcinoma cells.
    Tsui KH; Chung LC; Feng TH; Lee TY; Chang PL; Chen WT; Juang HH
    Prostate; 2015 May; 75(6):603-15. PubMed ID: 25560459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms.
    Morello F; Saglio E; Noghero A; Schiavone D; Williams TA; Verhovez A; Bussolino F; Veglio F; Mulatero P
    Atherosclerosis; 2009 Nov; 207(1):38-44. PubMed ID: 19426978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
    Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium transport is modulated by p38 kinase-dependent cross-talk between ENaC and Na,K-ATPase in collecting duct principal cells.
    Wang YB; Leroy V; Maunsbach AB; Doucet A; Hasler U; Dizin E; Ernandez T; de Seigneux S; Martin PY; Féraille E
    J Am Soc Nephrol; 2014 Feb; 25(2):250-9. PubMed ID: 24179170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the Hypoxia-Inducible Factor Pathway Inhibits Epithelial Sodium Channel-Mediated Sodium Transport in Collecting Duct Principal Cells.
    Dizin E; Olivier V; Roth I; Sassi A; Arnoux G; Ramakrishnan S; Morel S; Kwak BR; Loffing J; Hummler E; Wenger RH; Frew IJ; Feraille E
    J Am Soc Nephrol; 2021 Dec; 32(12):3130-3145. PubMed ID: 34615708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity.
    Kim KH; Lee GY; Kim JI; Ham M; Won Lee J; Kim JB
    J Lipid Res; 2010 Dec; 51(12):3425-33. PubMed ID: 20847297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LXR agonism improves TNF-α-induced endothelial dysfunction in the absence of its cholesterol-modulating effects.
    Spillmann F; Van Linthout S; Miteva K; Lorenz M; Stangl V; Schultheiss HP; Tschöpe C
    Atherosclerosis; 2014 Jan; 232(1):1-9. PubMed ID: 24401210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ankyrin G Expression Regulates Apical Delivery of the Epithelial Sodium Channel (ENaC).
    Klemens CA; Edinger RS; Kightlinger L; Liu X; Butterworth MB
    J Biol Chem; 2017 Jan; 292(1):375-385. PubMed ID: 27895120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver X Receptor Regulates Triglyceride Absorption Through Intestinal Down-regulation of Scavenger Receptor Class B, Type 1.
    Briand O; Touche V; Colin S; Brufau G; Davalos A; Schonewille M; Bovenga F; Carrière V; de Boer JF; Dugardin C; Riveau B; Clavey V; Tailleux A; Moschetta A; Lasunción MA; Groen AK; Staels B; Lestavel S
    Gastroenterology; 2016 Mar; 150(3):650-8. PubMed ID: 26602218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ENaC inhibition stimulates Cl- secretion in the mouse cortical collecting duct through an NKCC1-dependent mechanism.
    Pech V; Thumova M; Kim YH; Agazatian D; Hummler E; Rossier BC; Weinstein AM; Nanami M; Wall SM
    Am J Physiol Renal Physiol; 2012 Jul; 303(1):F45-55. PubMed ID: 22496413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver X receptor activation reduces angiogenesis by impairing lipid raft localization and signaling of vascular endothelial growth factor receptor-2.
    Noghero A; Perino A; Seano G; Saglio E; Lo Sasso G; Veglio F; Primo L; Hirsch E; Bussolino F; Morello F
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2280-8. PubMed ID: 22723445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of LXRs using the synthetic agonist GW3965 represses the production of pro-inflammatory cytokines by murine mast cells.
    Nunomura S; Okayama Y; Matsumoto K; Hashimoto N; Endo-Umeda K; Terui T; Makishima M; Ra C
    Allergol Int; 2015 Sep; 64 Suppl():S11-7. PubMed ID: 26344074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver X receptor activation inhibits osteoclastogenesis by suppressing NF-κB activity and c-Fos induction and prevents inflammatory bone loss in mice.
    Kim HJ; Yoon KA; Yoon HJ; Hong JM; Lee MJ; Lee IK; Kim SY
    J Leukoc Biol; 2013 Jul; 94(1):99-107. PubMed ID: 23657115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AF17 facilitates Dot1a nuclear export and upregulates ENaC-mediated Na+ transport in renal collecting duct cells.
    Wu H; Chen L; Zhou Q; Zhang W
    PLoS One; 2011; 6(11):e27429. PubMed ID: 22087315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.